Keywords: genzyme, completes, atiii, trial, transgenics, completed, phase

Genzyme Completes ATIII Trial

Article | 18 September 1997

Genzyme Transgenics has completed a Phase II trial of its flagshipproduct, recombinant human antithrombin III, which is produced in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in